| scholarly article | Q13442814 |
| P356 | DOI | 10.3899/JRHEUM.131279 |
| P698 | PubMed publication ID | 25128506 |
| P50 | author | Filip De Keyser | Q49150640 |
| P2093 | author name string | Patrick Durez | |
| Rene Westhovens | |||
| Ilse Hoffman | |||
| Marie-Joëlle Kaiser | |||
| MIRA Study Group | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| rituximab | Q412323 | ||
| P304 | page(s) | 1761-1765 | |
| P577 | publication date | 2014-08-15 | |
| P1433 | published in | The Journal of Rheumatology | Q7743623 |
| P1476 | title | Longterm followup of rituximab therapy in patients with rheumatoid arthritis: results from the Belgian MabThera in Rheumatoid Arthritis registry | |
| P478 | volume | 41 |
| Q58800375 | A Targeted Literature Review Examining Biologic Therapy Compliance and Persistence in Chronic Inflammatory Diseases to Identify the Associated Unmet Needs, Driving Factors, and Consequences |
| Q53445087 | Anti-citrullinated-protein-antibody-specific intravenous immunoglobulin attenuates collagen-induced arthritis in mice. |
| Q51013068 | Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA). |
| Q40055726 | Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis. |
| Q47658821 | Comparative evaluation of treatment patterns and healthcare utilization of newly-diagnosed rheumatoid arthritis patients by anti-cyclic citrullinated peptide antibody status |
| Q85272628 | Efficacy and safety of a biosimilar rituximab in biologic naïve patients with active rheumatoid arthritis |
| Q52642633 | Long-term persistence with rituximab in patients with rheumatoid arthritis. |
| Q38816869 | Monoclonal antibody therapy for neuromyelitis optica spectrum disorder: current and future |
| Q50674920 | Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis. |
| Q89939143 | Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis - A Systematic Literature Review |
| Q55234556 | Targeting B Cells and Plasma Cells in Autoimmune Diseases. |
| Q38800650 | Tocilizumab treatment leads to improvement in disease activity regardless of CCP status in rheumatoid arthritis |
Search more.